Influence of Thyroid Hormones on Haemostasis

Kavitha Thilak *

Allied Health Sciences, Srinivas University, Mangalore, Karnataka, India.

Sukesh

Department of Pathology, Srinivas Institute of Medical Sciences and Research Centre, Mangalore, Karnataka, India.

*Author to whom correspondence should be addressed.


Abstract

Aim: The aim of this research study is to investigate the association and impact of thyroid disorders on haemostasis, specifically focusing on the clotting and bleeding tendencies in patients with thyroid function disorders.

Globally, thyroid gland disorders are a common cause of illness. Increased thyroid gland hormones can result in a variety of disorders, ranging in severity from minor symptoms to fatal diseases. Here, we go over how thyroid hormone can influence the hemostatic system and the danger of bleeding and venous thromboembolism that goes along with it. Hypothyroid people are more likely to experience bleeding issues, which may be important for patients undergoing invasive operations. Physicians should also be mindful of the probability of hyperthyroidism as risk factor for venous thromboembolism, particularly in instances with no apparent cause. To learn more about the relevance of these findings for general practice, clinical investigations are required.

There have been instances of both hypercoagulable and hypocoagulable conditions, which raises concerns about how subclinical hypothyroidism (SCH) affects hemostasis. Therefore, the goal of our study is to examine the importance of clinical trials in this setting.

Keywords: Hyperthyroidism, hypothyroidism, blood coagulation, fibrinolysis, bleeding, venous thrombosis


How to Cite

Thilak, Kavitha, and Sukesh. 2023. “Influence of Thyroid Hormones on Haemostasis”. International Journal of Research and Reports in Hematology 6 (2):244-51. https://journalijr2h.com/index.php/IJR2H/article/view/130.

Downloads

Download data is not yet available.

References

Ogbera AO, Kuku SF. Epidemiology of thyroid diseases in Africa. Indian Journal of Endocrinology and Metabolism. 2011; 15(Suppl2):S82.

Burtis C, Ashwood E, Bruns D, Tietz N. Tietz fundamentals of clinical chemistry. 1st ed. Philadelphia: Saunders Elsevier. 2008;766.

Ordookhani A, Burman KD. Hemostasis in hypothyroidism and autoimmune thyroid disorders. International Journal of Endocrinology and Metabolism. 2017; 15(2).

Maia AL, Goemann IM, Meyer ELS, Wajner SM. Type 1 iodothyronine deiodinase in human physiology and disease. Journal of Endocrinology. 2011; 209(3):283-297.

Mansourian AR. Metabolic pathways of tetraidothyronine and triidothyronine production by thyroid gland: A review of articles. Pakistan Journal of Biological Sciences: PJBS. 2011;14(1):1-12.

Bishop ML. Clinical Chemistry: Principles, Techniques, and Correlations, Enhanced Edition: Principles, Techniques, and Correlations. Jones & Bartlett Learning; 2020.

Teng X, Shan Z, Chen Y, Lai Y, Yu J, Shan L, et al. More than adequate iodine intake may increase subclinical hypothyroidism and autoimmune thyroiditis: A cross-sectional study based on two Chinese communities with different iodine intake levels. European Journal of Endocrinology. 2011;164(6):943- 950.

Sharma A, Stan MN. Thyrotoxicosis: Diagnosis and management. In Mayo Clinic Proceedings. Elsevier. 2019, June; 94(6):1048-1064.

Kravets I. Hyperthyroidism: Diagnosis and treatment. American Family Physician. 2016;93(5):363-370.

LiVolsi VA, Baloch ZW. The pathology of hyperthyroidism. Frontiers in Endocrinology. 2018;9:737.

De Leo S, Lee SY, Braverman LE. Hyperthyroidism. The Lancet. 2016; 388(10047):906-918.

Ross DS. Diagnosis of hyperthyroidism. UpToDate, Waltham, MA. Accessed, 20 2017.

Squizzato A, Romualdi E, Buller HR, Gerdes VEA. Thyroid dysfunction and effects on coagulation and fibrinolysis: A systematic review. The Journal of Clinical Endocrinology & Metabolism. 2007;92(7): 2415-2420.

Saritha Mary Thomas, Abin Varghese. Pre-Analytical Variables in Coagulation Studies; International Journal of Scientific and Research Publications (IJSRP). 2022; 12(12).

(ISSN: 2250-3153). DOI: http://dx.doi.org/10.29322/IJSRP.12.12.2022.p13235

Yusof NNM, McCann A, Little PJ, Ta HT. Non-invasive imaging techniques for the differentiation of acute and chronic thrombosis. Thromb. Res. 2019 May;177: 161-171.

Preijers T, Schütte LM, Kruip MJ, Cnossen MH, Leebeek FW, van Hest RM, Mathôt RA. Strategies for individualized dosing of clotting factor concentrates and desmopressin in hemophilia A and B. Therapeutic Drug Monitoring. 2019;41(2): 192-212.

Weisel JW, Litvinov RI. Red blood cells: The forgotten player in hemostasis and thrombosis. Journal of Thrombosis and Haemostasis. 2019;17(2):271-282.

Hofbauer LC, Heufelder AE. Coagulation disorders in thyroid diseases. European Journal of Endocrinology. 1997;136(1):1-7.

Kim DDW, Chunilal S, Young S, Cutfield R. A study of venous thrombosis incidence in patients with acute hyperthyroidism. Internal Medicine Journal. 2013;43(4):361-365.

Mohamedahmed KA, Ahmed AH, Talha AA, Babker A. Alteration of Coagulation Profiles in Hypothyroid Patients. International Journal of Current Research in Physiology and Pharmacology. 2022;1-5.

AL Farrah BA. Assessment of the relationship between thyroid diseases involvement and effect on hemostasis; A prospective analysis of hemostasis profiles in women with control group in Saudi Arabia.

Yadav P, Shah N, Chaudhari RK. Assessment of Coagulation Profile among Subclinical Hypothyroid Patients Attending Immunoassay Lab, BPKIHS, Dharan. World J Clin Pathol. 2019;2(1):1007.

Alsaidan AA, Alruwiali F. Association between hyperthyroidism and thromboembolism: A retrospective observational study. Annals of African Medicine. 2023;22(2):183.

Erem CİHANGİR, Ersoz HÖ, Karti SS, Ukinç KUBİLAY, Hacihasanoglu A, Değer O, Telatar M. Blood coagulation and fibrinolysis in patients with hyperthyroidism. Journal of Endocrinological Investigation. 2002;25: 345-350.

Farid NR, Griffiths BL, Collins JR, Marshall WH, Ingram DW. Blood coagulation and fibrinolysis in thyroid disease. Thrombosis and Haemostasis. 1976;35(02):415-422.

Erem CİHANGİR, Kavgaci HALİL, Ersöuz HÖ, Hacihasanoglu A, Ukinç KUBİLAY, Karti SS, et al. Blood coagulation and fibrinolytic activity in hypothyroidism. International Journal of Clinical Practice. 2003;57(2):78-81.

Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: Subclinical hyperthyroidism increases plasma factor X activity. Clinical Endocrinology. 2006;64(3): 323-329.

Mohamed-Ali MS, Ahmed RO. Coagulation profiles in hypothyroid and hyperthyroid female patients in Sudan. Saudi Medical Journal. 2008;29(9):1289-1293.

Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. The Journal of Clinical Endocrinology & Metabolism. 2001;86(2): 732-737.

Danescu LG, Badshah A, Danescu SC, Janjua M, Marandici AM, Matta F, et al. Venous thromboembolism in patients hospitalized with thyroid dysfunction. Clinical and Applied Thrombosis/ Hemostasis. 2009;15(6):676-680.

Müller B, Tsakiris DA, Roth CB, Guglielmetti M, Staub JJ, Marbet GA. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. European Journal of Clinical Investigation. 2001;31(2):131-137.

van Zaane B, Squizzato A, Huijgen R, van Zanten AP, Fliers E, Cannegieter SC, et al. Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: A case-control study. Blood, The Journal of the American Society of Hematology. 2010;115(22):4344-4349.

Debeij J, Cannegieter SC, van Zaane B, Smit JW, Corssmit EP, Rosendaal FR, et al. The effect of changes in thyroxine and thyroid‐stimulating hormone levels on the coagulation system. Journal of Thrombosis and Haemostasis. 2010;8(12):2823-2826.

Ordookhani A, Burman KD. Hemostasis in overt and subclinical hyperthyroidism. International Journal of Endocrinology and Metabolism. 2017;15(3).

Lupoli R, Di Minno MND, Tortora A, Scaravilli A, Cacciapuoti M, Barba L, et al. Primary and secondary hemostasis in patients with subclinical hypothyroidism: Effect of levothyroxine treatment. The Journal of Clinical Endocrinology & Metabolism. 2015;100(7):2659-2665.

Chadarevian R, Bruckert E, Giral P, Turpin G. Relationship between thyroid hormones and fibrinogen levels. Blood Coagulation & Fibrinolysis. 1999;10(8):481-486.

Thoyyib M, Garg S, Gupta N, Aggarwal S, Pandit S. Study on coagulation factor VIII and fibrinogen levels in patients with thyroid disorders. Indian Journal of Endocrinology and Metabolism. 2018; 22(4):479.

Guldiken S, Demir M, Turgut B, Altun BU, Arikan E, Kara M. Global fibrinolytic capacity in patients with subclinical hypothyroidism. Endocrine Journal. 2005; 52(3):363-367.

Hume R. Fibrinolytic activity and thyroid function. British Medical Journal, 1965; 1(5436):686.

Peralta AR, Canhão P. Hypothyroidism and cerebral vein thrombosis–a possible association. Journal of Neurology. 2008; 255:962-966.

Cuianu M, Nussbaum A, Cristea A, Vlăduţiu T, Roman S, Stoica D. High levels of plasma von Willebrand factor in hyperthyroidism. Medecine Interne. 1987;25(3):205-210.

Özcan MA, Çömlekçi A, Demirkan F, Yüksel F, Sarı I, Demir T, et al. Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders. Thrombosis Research. 2003;110(4):243-247.

Yango J, Alexopoulou O, Eeckhoudt S, Hermans C, Daumerie C. Evaluation of the respective influence of thyroid hormones and TSH on blood coagulation parameters after total thyroidectomy. European Journal of Endocrinology. 2011;164(4):599-603.

Lippi G, Franchini M, Targher G, Montagnana M, Salvagno GL, Guidi GC, et al. Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients. Journal of Thrombosis and Thrombolysis. 2009;28: 362-365.

Rogers JS, Shane SR, Jencks FS. Factor VIII activity and thyroid function. Annals of Internal Medicine. 1982;97(5):713-716.

Rennie JAN, Bewsher PD, Murchison LE, Ogston D. Coagulation and fibrinolysis in thyroid disease. Acta Haematologica. 1978;59(3):171-177.

Franchini M. Hemostasis and thyroid diseases revisited. Journal of Endocrinological Investigation. 2004;27: 886-892.

Ford HC, Carter JM. Haemostasis in hypothyroidism. Postgraduate Medical Journal. 1990;66(774):280-284.

Gullu S, Sav H, Kamel N. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. European Journal of Endocrinology. 2005;152(3):355-361.

Soni S, Singh G, Yasir S, Hatipoglu B. An unusual presentation of hypothyroidism. Thyroid. 2005;15(3):289-291.

Egeberg O. Influence of thyroid function on the blood clotting system. Scandinavian Journal of Clinical and Laboratory Investigation. 1963;15(1):1-7.

Simone JV, Abildgaard CF, Sghulman I. Blood coagulation in thyroid dysfunction. New England Journal of Medicine. 1965; 273(20):1057-1061.

Nordøy A, Vik‐Mo H, Berntsen H. Haemostatic and lipid abnormalities in hypothyroidism. Scandinavian Journal of Haematology. 1976;16(2):154-160.

Farid NR, Griffiths BL, Collins JR, Marshall WH, Ingram DW. Blood coagulation and fibrinolysis in thyroid disease. Thrombosis and Haemostasis. 1976;35(02):415-422.

Marongiu F, Conti M, Murtas ML, Mameli G, Sorano GG, Martino E. Activation of blood coagulation and fibrinolysis in Graves' disease. Hormone and Metabolic Research. 1991;23(12):609-611.

Marongiu F, Biondi G, Conti M, Murtas ML, Mameli G, Sorano GG, Martinox E. Is a hypercoagulable state present in hypothyroidism?. Thrombosis and haemostasis. 1992;67(06):729-729.

Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study. Annals of Internal Medicine. 2000; 132(4):270-278.

Chadarevian R, Bruckert E, Ankri A, Beucler I, Giral P, Turpin G. Relationship between thyroid hormones and plasma D-dimer levels. Thrombosis and Haemostasis. 1998;59(01):99-103.

Marongiu F, Conti M, Murtas ML, Sorano GG, Mameli G, Salis G, et al E. Anticardiolipin antibodies in Grave's disease: Relationship with thrombin activity in vivo. Thrombosis Research. 1991; 64(6):745-749.

Dagenais P, Urowitz MB, Gladman DD, Norman CS. A family study of the antiphospholipid syndrome associated with other autoimmune diseases. The Journal of Rheumatology. 1992;19(9):1393-1396.